Form 4: UnitedHealth Director Valerie Montgomery Rice Receives Quarterly Stock Compensation

UnitedHealth Group director Valerie Montgomery Rice MD was granted 288 deferred stock units as part of her regular quarterly compensation, increasing her beneficial ownership to 6,587 shares.

Summary

• Valerie C. Montgomery Rice M.D., a Director of UnitedHealth Group Inc. (UNH), acquired 288 shares of common stock.
• The transaction occurred on July 1, 2025.
• These shares represent deferred stock units granted as regular quarterly compensation for her service as a director.
• The deferred stock units are immediately vested but must be retained until her completion of service on the Board.
• Following this transaction, Valerie C. Montgomery Rice M.D. beneficially owns 6,587 shares of UnitedHealth Group common stock.
• The acquisition price per share was $0, indicating a grant rather than a purchase.

Sentiment

Score: 7

Explanation: The filing indicates a routine, expected transaction related to director compensation, which is a positive sign of stable corporate governance and alignment of interests, but it does not contain information that would significantly alter the company's financial outlook or strategic direction.

Positives

• Demonstrates ongoing commitment and alignment of a director's interests with shareholders through equity compensation.
• The grant of deferred stock units is a standard practice for director compensation, indicating stable corporate governance practices.

Future Outlook

No forward-looking statements or guidance are provided in this filing, as it pertains to a past transaction.

Industry Context

The grant of deferred stock units as compensation for directors is a common practice across many publicly traded companies, particularly in the healthcare and insurance sectors, aligning director incentives with long-term shareholder value.

Comparison to Industry Standards

• Director compensation through equity grants, such as deferred stock units, is a widely accepted practice in corporate governance across industries, including healthcare.
• This aligns the interests of directors with shareholders by tying a portion of their compensation to the company's stock performance.
• This practice is consistent with compensation structures at large-cap companies like CVS Health (CVS), Anthem (ANTM), or Humana (HUM), which also utilize equity-based compensation for their board members.

Corporate Governance

Related Party Transactions

• The grant of deferred stock units to a director as compensation is a standard and disclosed form of remuneration for board service, which can be considered a related party transaction.

Stakeholder Impact

• Shareholders: The grant aligns the director's interests with shareholders by tying compensation to equity, potentially fostering long-term value creation.

Key Dates

Keywords

UnitedHealth Group, UNH, Form 4, SEC filing, Director compensation, Stock grant, Deferred stock units, Insider transaction, Valerie Montgomery Rice, Equity compensation